Associated Papers
Potential elucidation of a novel CTL epitope in HIV-1 protease by the protease inhibitor resistance mutation L90M.
Smidt W
Plos One, 2013
Molecular epidemiology of HIV in two highly endemic areas of northeastern South Africa.
Iweriebor BC et al.
Archives of Virology, 2012
Atazanavir signature I50L resistance substitution accounts for unique phenotype of increased susceptibility to other protease inhibitors in a variety of human immunodeficiency virus type 1 genetic backbones.
Weinheimer S et al.
Antimicrobial Agents and Chemotherapy, 2005
Transmission of antiretroviral-drug-resistant HIV-1 variants.
Yerly S et al.
Lancet (london, England), 1999
Select a paper to view details